Heath 1 described a three-year-old boy without evidence of existing Central-nervous-system disease who received 3 or 4 applications of 0.8 per cent atropine ointment, a total of approximately 1.6 mg.

It is available as either a drop or an ointment. Atropine is FDA-approved for dilating the pupil and temporarily paralyzing the muscle of the eye that adapts the lens to sharp vision at different ...